Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
N/A
Address
Description
Holista CollTech Ltd. engages in the research and development, manufacture, and marketing of natural ingredients and wellness products. It operates through the following segments: Ovine Collagen, Infection Control, Dietary Supplements, and Food Ingredients. The company was founded by Rajen Manicka on September 18, 2000 and is headquartered in Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.07
Trade Value (12mth)
AU$1,560.00
1 week
17.86%
1 month
13.79%
YTD
312.5%
1 year
1220%
All time high
2.21
EPS 3 yr Growth
-93.50%
EBITDA Margin
-15.50%
Operating Cashflow
-$1m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-7.30
Quick Ratio
0.30
Shares on Issue (Fully Dilluted)
279m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
03 July 25 |
Appointment of Chief Executive Officer
×
Appointment of Chief Executive Officer |
18 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
18 June 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
17 June 25 |
Application for quotation of securities - HCT
×
Application for quotation of securities - HCT |
17 June 25 |
Cleansing Notice
×
Cleansing Notice |
30 May 25 |
AGM Presentation and Clarification on Licensing Agreement
×
AGM Presentation and Clarification on Licensing Agreement |
29 May 25 |
Results of Meeting
×
Results of Meeting |
27 May 25 |
Update on Collagen Business
×
Update on Collagen Business |
16 May 25 |
Initial and Final Director Interest Notices
×
Initial and Final Director Interest Notices |
14 May 25 |
Board Changes
×
Board Changes |
12 May 25 |
Response to ASX Price Query
×
Response to ASX Price Query |
30 April 25 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 April 25 |
Notification regarding unquoted securities - HCT
×
Notification regarding unquoted securities - HCT |
29 April 25 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
28 April 25 |
Update - Notification regarding unquoted securities - HCT
×
Update - Notification regarding unquoted securities - HCT |
24 April 25 |
Appointment of Chairperson
×
Appointment of Chairperson |
17 April 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
17 April 25 |
Notification regarding unquoted securities - HCT
×
Notification regarding unquoted securities - HCT |
16 April 25 |
Resignation of Non-Executive Directors
×
Resignation of Non-Executive Directors |
01 April 25 |
Supreme Court Proceedings against ProImmune
×
Supreme Court Proceedings against ProImmune |
01 April 25 |
Suspension from Quotation
×
Suspension from Quotation |
01 April 25 |
Annual Report to shareholders
×
Annual Report to shareholders |
01 April 25 |
Appendix 4G
×
Appendix 4G |
01 April 25 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
26 March 25 |
Director Appointment
×
Director Appointment |
12 March 25 |
Update - Proposed issue of securities - HCT
×
Update - Proposed issue of securities - HCT |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.